Immunotherapy for Parkinson’s disease von Schwab, Aaron D., Thurston, Mackenzie J., Machhi, Jatin, Olson, Katherine E., Namminga, Krista L., Gendelman, Howard E., Mosley, R. Lee

Volltext

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders von Machhi, Jatin, Kevadiya, Bhavesh D., Muhammad, Ijaz Khan, Herskovitz, Jonathan, Olson, Katherine E., Mosley, R. Lee, Gendelman, Howard E.

Volltext

CD4+effector T cells accelerate Alzheimer's disease in mice von Machhi, Jatin, Yeapuri, Pravin, Lu, Yaman, Foster, Emma, Chikhale, Rupesh, Herskovitz, Jonathan, Namminga, Krista L., Olson, Katherine E., Abdelmoaty, Mai Mohamed, Gao, Ju, Quadros, Rolen M., Kiyota, Tomomi, Liang Jingjing, Kevadiya, Bhavesh D., Wang, Xinglong, Liu, Yutong, Poluektova, Larisa Y., Gurumurthy, Channabasavaiah B., Mosley, R. Lee, Gendelman, Howard E.

Volltext

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions von Abdelmoaty, Mai M., Yeapuri, Pravin, Machhi, Jatin, Olson, Katherine E., Shahjin, Farah, Kumar, Vikas, Zhou, You, Liang, Jingjing, Pandey, Kabita, Acharya, Arpan, Byrareddy, Siddappa N., Mosley, R. Lee, Gendelman, Howard E.

Volltext

Amyloid-β specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice von Yeapuri, Pravin, Machhi, Jatin, Lu, Yaman, Abdelmoaty, Mai Mohamed, Kadry, Rana, Patel, Milankumar, Bhattarai, Shaurav, Lu, Eugene, Namminga, Krista L, Olson, Katherine E, Foster, Emma G, Mosley, R Lee, Gendelman, Howard E

Volltext

Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice von Olson, Katherine E, Kosloski-Bilek, Lisa M, Anderson, Kristi M, Diggs, Breha J, Clark, Barbara E, Gledhill, Jr, John M, Shandler, Scott J, Mosley, R Lee, Gendelman, Howard E

Volltext

Diffusion of Technology: Frequency of use for Younger and Older Adults von Olson, Katherine E., O’Brien, Marita A., Rogers, Wendy A., Charness, Neil

Volltext

Humanized Mice for Infectious and Neurodegenerative disorders von Dash, Prasanta K., Gorantla, Santhi, Poluektova, Larisa, Hasan, Mahmudul, Waight, Emiko, Zhang, Chen, Markovic, Milica, Edagwa, Benson, Machhi, Jatin, Olson, Katherine E., Wang, Xinglong, Mosley, R. Lee, Kevadiya, Bhavesh, Gendelman, Howard E.

Volltext

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease von Mosley, R. Lee, Lu, Yaman, Olson, Katherine E., Machhi, Jatin, Yan, Wenhui, Namminga, Krista L., Smith, Jenell R., Shandler, Scott J., Gendelman, Howard E.

Volltext

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial von Gendelman, Howard E., Zhang, Yuning, Santamaria, Pamela, Olson, Katherine E., Schutt, Charles R., Bhatti, Danish, Shetty, Bhagya Laxmi Dyavar, Lu, Yaman, Estes, Katherine A., Standaert, David G., Heinrichs-Graham, Elizabeth, Larson, LuAnn, Meza, Jane L., Follett, Matthew, Forsberg, Erica, Siuzdak, Gary, Wilson, Tony W., Peterson, Carolyn, Mosley, R. Lee

Volltext

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease von Olson, Katherine E., Namminga, Krista L., Lu, Yaman, Schwab, Aaron D., Thurston, Mackenzie J., Abdelmoaty, Mai M., Kumar, Vikas, Wojtkiewicz, Melinda, Obaro, Helen, Santamaria, Pamela, Mosley, R. Lee, Gendelman, Howard E.

Volltext

An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers von Olson, Katherine E, Abdelmoaty, Mai M, Namminga, Krista L, Lu, Yaman, Obaro, Helen, Santamaria, Pamela, Mosley, R Lee, Gendelman, Howard E

Volltext

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease von Abdelmoaty, Mai M., Machhi, Jatin, Yeapuri, Pravin, Shahjin, Farah, Kumar, Vikas, Olson, Katherine E., Mosley, R. Lee, Gendelman, Howard E.

Volltext

The potential for treg-enhancing therapies in nervous system pathologies von Olson, Katherine E, Mosley, R L, Gendelman, Howard E

Volltext

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease von Olson, Katherine E, Gendelman, Howard E

Volltext

Development of an extended half-life GM-CSF fusion protein for Parkinson's disease von Yeapuri, Pravin, Olson, Katherine E., Lu, Yaman, Abdelmoaty, Mai Mohamed, Namminga, Krista L., Markovic, Milica, Machhi, Jatin, Mosley, R. Lee, Gendelman, Howard E.

Volltext

Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease von Olson, Katherine E., Namminga, Krista L., Lu, Yaman, Thurston, Mackenzie J., Schwab, Aaron D., de Picciotto, Seymour, Tse, Sze-Wah, Walker, William, Iacovelli, Jared, Small, Clayton, Wipke, Brian T., Mosley, R. Lee, Huang, Eric, Gendelman, Howard E.

Volltext

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice von Kosloski, Lisa M, Kosmacek, Elizabeth A, Olson, Katherine E, Mosley, R. Lee, Gendelman, Howard E

Volltext

Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice von Olson, Katherine E., Namminga, Krista L., Schwab, Aaron D., Thurston, Mackenzie J., Lu, Yaman, Woods, Ashley, Lei, Lei, Shen, Weijun, Wang, Feng, Joseph, Sean B., Gendelman, Howard E., Mosley, R. Lee

Volltext

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders von Anderson, Kristi M, Olson, Katherine E, Estes, Katherine A, Flanagan, Ken, Gendelman, Howard E, Mosley, R Lee

Volltext